Entheon Biomedical CEO Timothy Ko (CSE: ENBI) (OTC: ENTBF) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction with DMT. Entheon Biomedical is pioneering a leading-edge addiction recovery solution that harnesses and optimizes the therapeutic potential of the DMT molecule. Entheon exists to invert the addiction-recovery ratio, turning the ‘untreatable case’ and ‘lost cause’ from the norm to the exception. Entheon Biomedical is developing a DMT-assisted therapeutic protocol that will be specifically tailored to address the core mechanisms underlying drug-seeking and using behavior. Our chief aim is to provide an effective and scalable therapeutic protocol that will serve as a vital resource for those afflicted with a substance-use disorder, and who are wanting to reclaim their lives. Entheon's DMT clinical trial later this year will put it in direct competition with MindMed (MMED /MMEDF), who is also planning on launching a DMT clinical trial later this year. I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor Facebook: @thepsychedelicinvestor For any potential collaborations, please reach us at: thepsychedelicinvestor@gmail.com Music: www.bensound.com DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change. The Psychedelic Investor was compensated $1,000 by Future Money Trends for the making of this video on Entheon Biomedical. James (The Psychedelic Investor) does not own a position in Entheon Biomedical and will not open one for at least 30 days after publication of this video. https://entheonbiomedical.com/ CSE: ENBI | OTCQB: ENTBF This video was conducted on behalf of Entheon Biomedical, and was funded by Gold Standard Media LLC. For our full disclaimer, please visit: https://www.goldstandardir.com/entheon-biomedical-disclaimer-85/ #EntheonBiomedical​​​ ​#Entheon​​​ #PsychedelicStocks

In today's episode of "This Week in Psychedelic Stocks", we have News on MindMed (MMED / MMEDF/MMQ), Compass Pathways (CMPS), Cybin (CYBN) , Core One Labs ( COOL) & Lobe Sciences (LOBE). I covered some breaking news on MindMed yesterday in our impromptu episode on the MindMed stock being added to the FTSE so that MMED / MMEDF news is not in this episode. However, this wasn't the only big news this week. Compass Pathways (CMPS) received not one but 2 new patents and surely, some of you might find this news worth discussing... We will cover the latest developments in the field writ large. This means we will cover any stories that affect the all the companies in this field, as well as company specific developments. Timestamps: 0:00​ - Intro 1:18​ - New Psychedelic ETF (PSIL) 5:44​ - Baltimore decriminalizes the possession of all drugs 6:53​ - Hawaii to study the benefits of psilocybin 8:29​ - Harvard University to study psychedelics 9:42​ - UCSF also decides to study psychedelics 11:24​ - MindMed (MMED / MMEDF / MMQ) announced the company's 2020 End-Year Financial results + link 12:32​ on video end year 12:50​ - MindMed files F10 File with the SEC ( important step before uplisting to the NASDAQ) 14:11​ - MindMed's 2020 conference call highlights 15:06​ - MindMed (MMED) has now filed a patent application for its 18-MC compound 17:04​ - Cybin (CYBN / CLXPF) management restructuring 19:40​ - Core One Labs (COOL ) stock updates 20:48 - Lobe Sciences ( Lobe) company updates So that's it for This Week in Psychedelic Stocks fellow psychedelic investors! I hope you guys found some value in this and I'll keep you posted for more changes! Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news! Follow us on social media! 🙌 Instagram: @psychedelicinvestor email: thepsychedelicinvestor@gmail.com Facebook: @thepsychedelicinvestor Music: www.bensound.com https://benzinga.grsm.io/jameshallifa... ​ https://benzinga.grsm.io/thepsychedel... ​ DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments. #MindMed​​​ ​#MMED​​​ #MindMedStock​

Psychedelic research is coming to the University of California in a new division to study MDMA.